Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daphne Stewart

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Clinical Medicine|May 28, 2020
Strategies to Improve Participation of Older Adults in Cancer ResearchJennifer Liu, Eutiquio Gutierrez, Abhay Tiwari, et al.
Frontiers in Oncology|August 16, 2024
Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Therapeutic Advances in Medical Oncology|November 29, 2023
CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case studyYuan Yuan, Colt Egelston, Oscar Colunga Flores, et al.
Annals of Surgical Oncology|October 1, 2025
Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Annals of Surgical Oncology|October 29, 2025
ASO Visual Abstract: Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Ovarian Cancer Patients with Peritoneal Metastases-A Multicenter U.S. Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
The Oncologist|October 24, 2020
Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Clinical Medicine|May 28, 2020
Strategies to Improve Participation of Older Adults in Cancer ResearchJennifer Liu, Eutiquio Gutierrez, Abhay Tiwari, et al.
Frontiers in Oncology|August 16, 2024
Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Therapeutic Advances in Medical Oncology|November 29, 2023
CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case studyYuan Yuan, Colt Egelston, Oscar Colunga Flores, et al.
Annals of Surgical Oncology|October 1, 2025
Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Annals of Surgical Oncology|October 29, 2025
ASO Visual Abstract: Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Ovarian Cancer Patients with Peritoneal Metastases-A Multicenter U.S. Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
The Oncologist|October 24, 2020
Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, et al.
Pageof 3